1KIDD KE, ALTMAN DG. Adherence in social context [J]. Control Clin Trials, 2000,21(5 Suppl) : 184S-187S.
2SHUMAKER SA, DUGAN E, BOWEN DJ. Ehancing adherence in randomized controlled clincial trials [ J ]. Control Clin Trials,2000,21 (5 Suppl) :226S-232S.
3CASEY DE. Barrievs to progress-the impact of tolerablity problems[J]. Int Clin Psychopharmacol, 2001,16 Suppl 1 :S15-S19.
4RUDD P, LENERT L. Pharmacokinetics as an aid to optimising compliance with medications [ J ]. Clin Pharmacoklnet, 1995,28(1):1-6.
5VITOLINS MZ, RAND CS, RAPP SR, et al. Measuring adherence to behavioral and medical interventions [J]. Control Clin Trials ,2000,21 (5 Suppl) :188S-194S.
6URQUHART J. Role of patient compliance in clinical pharmacokinetics: a review of recent research [J]. Clin Pharmacokinet, 1994,27(3) :202-215.
7GIL V,PINEDA M, MARTINEZ JL, et al. Validity of 6 indirect methods to assess treatment compliance in arterial hypertension[J]. Med Clin, 1994,102(14) :532-536.
8BOUDES P. Drug compliance in therapeutic trials[ J ]. Control Clin Trials, 1998,19(3) :257-268.
9LESAFFRE E, DE - KLERK E. Estimating the power of comliance- improving methods[J]. Control Clin Trials,2000,21(6) : 540-551.
10CRAMER JA. Microelectronic systems for monitoring and enhancing patient comliance with medication regimens[ J ]. Drugs, 1995,49(3) :321-327.
